Treatment with benfotiamine in patients with diabetic sensorimotor polyneuropathy: A double-blind, randomized, placebo-controlled, parallel group pilot study over 12 months

Ovidiu Alin Stirban; Helga Zeller-Stefan; Jochen Schumacher; Wilhelm Gaus; Dan Ziegler; Thomas Schuerholz; Rodica Pop-Busui

doi:10.1016/j.jdiacomp.2020.107757

Treatment with benfotiamine in patients with diabetic sensorimotor polyneuropathy: A double-blind, randomized, placebo-controlled, parallel group pilot study over 12 months

Journal of Diabetes and its Complications ◽

10.1016/j.jdiacomp.2020.107757 ◽

2020 ◽

Vol 34 (12) ◽

pp. 107757

Author(s):

Ovidiu Alin Stirban ◽

Helga Zeller-Stefan ◽

Jochen Schumacher ◽

Wilhelm Gaus ◽

Dan Ziegler ◽

...

Keyword(s):

Pilot Study ◽

Double Blind ◽

Sensorimotor Polyneuropathy ◽

Parallel Group

Download Full-text

A multicentre, double-blind, randomised, parallel group, placebo-controlled, dose-ranging pilot study of ethyl-eicosapentaenoate (ethyl-EPA) in patients with schizophrenia

http://isrctn.org/> ◽

10.1186/isrctn44218911 ◽

2012 ◽

Author(s):

Harald Murck

Keyword(s):

Pilot Study ◽

Double Blind ◽

Parallel Group ◽

Dose Ranging

Download Full-text

A multicentre, double-blind, randomised, parallel group, placebo-controlled, dose ranging pilot study of ethyl eicosapentaenoate (EPA) as adjunct therapy in patients who remain depressed following treatment with standard antidepressant therapy

http://isrctn.org/> ◽

10.1186/isrctn44366049 ◽

2012 ◽

Author(s):

Harald Murck

Keyword(s):

Pilot Study ◽

Antidepressant Therapy ◽

Double Blind ◽

Adjunct Therapy ◽

Parallel Group ◽

Dose Ranging

Download Full-text

Double-blind, randomised, parallel group pilot study comparing two botulinum toxin type A products for the treatment of blepharospasm

Journal of Neural Transmission ◽

10.1007/s00702-010-0529-x ◽

2010 ◽

Vol 118 (2) ◽

pp. 233-239 ◽

Cited By ~ 44

Author(s):

Bettina Wabbels ◽

Gerhard Reichel ◽

Antony Fulford-Smith ◽

Nicola Wright ◽

Peter Roggenkämper

Keyword(s):

Botulinum Toxin ◽

Pilot Study ◽

Botulinum Toxin Type A ◽

Type A ◽

Botulinum Toxin Type ◽

Double Blind ◽

Parallel Group

Download Full-text

Management of cancerization field with a medical device containing photolyase: a randomized, double-blind, parallel-group pilot study

Journal of the European Academy of Dermatology and Venereology ◽

10.1111/jdv.14209 ◽

2017 ◽

Vol 31 (9) ◽

pp. e401-e403 ◽

Cited By ~ 7

Author(s):

E. Moscarella ◽

G. Argenziano ◽

C. Longo ◽

S. Aladren

Keyword(s):

Pilot Study ◽

Medical Device ◽

Double Blind ◽

Parallel Group ◽

Cancerization Field

Download Full-text

A double blind parallel group pilot study of the effects of CJ-11,974 and placebo on perceptual and emotional responses to rectosigmoid distension in IBS patients

Gastroenterology ◽

10.1016/s0016-5085(00)85527-4 ◽

2000 ◽

Vol 118 (4) ◽

pp. A846 ◽

Cited By ~ 19

Author(s):

Oh-Young Lee ◽

Julie Munakata ◽

Bruce D. Naliboff ◽

Lin Chang ◽

Emeran A. Mayer

Keyword(s):

Pilot Study ◽

Emotional Responses ◽

Double Blind ◽

Parallel Group

Download Full-text

A Double-Blind, Placebo-Controlled, Parallel-Group Pilot Study of Milnacipran for Chronic Radicular Pain (Sciatica) Associated With Lumbosacral Disc Disease

The Primary Care Companion For CNS Disorders ◽

10.4088/pcc.14m01658 ◽

2014 ◽

Author(s):

David M. Marks ◽

Chi-Un Pae ◽

Ashwin A. Patkar

Keyword(s):

Pilot Study ◽

Radicular Pain ◽

Disc Disease ◽

Double Blind ◽

Double Blind Placebo ◽

Parallel Group

Download Full-text

P414. Cannabidiol for symptomatic treatment of ulcerative colitis: Results from a randomised, double-blind, placebo-controlled, parallel group, multi-centred pilot study

Journal of Crohn s and Colitis ◽

10.1093/ecco-jcc/jju027.533 ◽

2015 ◽

Vol 9 (suppl 1) ◽

pp. S287-S287 ◽

Cited By ~ 2

Keyword(s):

Ulcerative Colitis ◽

Pilot Study ◽

Symptomatic Treatment ◽

Double Blind ◽

Double Blind Placebo ◽

Parallel Group

Download Full-text

Efficacy and Safety of Cannabidiol and Tetrahydrocannabivarin on Glycemic and Lipid Parameters in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Pilot Study

Diabetes Care ◽

10.2337/dc16-0650 ◽

2016 ◽

Vol 39 (10) ◽

pp. 1777-1786 ◽

Cited By ~ 58

Author(s):

Khalid A. Jadoon ◽

Stuart H. Ratcliffe ◽

David A. Barrett ◽

E. Louise Thomas ◽

Colin Stott ◽

...

Keyword(s):

Type 2 Diabetes ◽

Pilot Study ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Parallel Group ◽

Lipid Parameters

Download Full-text

A randomized, double-blind, active-controlled, parallel-group pilot study to compare the efficacy and sedative effects of desloratadine 5 mg with levocetirizine 5 mg in the treatment of chronic idiopathic urticaria

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2010.03.007 ◽

2010 ◽

Vol 63 (5) ◽

pp. e100-e102 ◽

Cited By ~ 8

Author(s):

Jin-Bon Hong ◽

Hsing-Chuan Lee ◽

Fu-Chang Hu ◽

Chia-Yu Chu

Keyword(s):

Pilot Study ◽

Chronic Idiopathic Urticaria ◽

Double Blind ◽

Parallel Group ◽

Sedative Effects

Download Full-text

Faculty Opinions recommendation of A randomized, double-blind, active-controlled, parallel-group pilot study to compare the efficacy and sedative effects of desloratadine 5 mg with levocetirizine 5 mg in the treatment of chronic idiopathic urticaria.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.5868956.5857054 ◽

2010 ◽

Author(s):

Alexander Marsland

Keyword(s):

Pilot Study ◽

Chronic Idiopathic Urticaria ◽

Double Blind ◽

Parallel Group ◽

Sedative Effects

Download Full-text

Treatment with benfotiamine in patients with diabetic sensorimotor polyneuropathy: A double-blind, randomized, placebo-controlled, parallel group pilot study over 12 months

A multicentre, double-blind, randomised, parallel group, placebo-controlled, dose-ranging pilot study of ethyl-eicosapentaenoate (ethyl-EPA) in patients with schizophrenia

A multicentre, double-blind, randomised, parallel group, placebo-controlled, dose ranging pilot study of ethyl eicosapentaenoate (EPA) as adjunct therapy in patients who remain depressed following treatment with standard antidepressant therapy

Double-blind, randomised, parallel group pilot study comparing two botulinum toxin type A products for the treatment of blepharospasm

Management of cancerization field with a medical device containing photolyase: a randomized, double-blind, parallel-group pilot study

A double blind parallel group pilot study of the effects of CJ-11,974 and placebo on perceptual and emotional responses to rectosigmoid distension in IBS patients

A Double-Blind, Placebo-Controlled, Parallel-Group Pilot Study of Milnacipran for Chronic Radicular Pain (Sciatica) Associated With Lumbosacral Disc Disease

P414. Cannabidiol for symptomatic treatment of ulcerative colitis: Results from a randomised, double-blind, placebo-controlled, parallel group, multi-centred pilot study

Efficacy and Safety of Cannabidiol and Tetrahydrocannabivarin on Glycemic and Lipid Parameters in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Pilot Study

A randomized, double-blind, active-controlled, parallel-group pilot study to compare the efficacy and sedative effects of desloratadine 5 mg with levocetirizine 5 mg in the treatment of chronic idiopathic urticaria

Faculty Opinions recommendation of A randomized, double-blind, active-controlled, parallel-group pilot study to compare the efficacy and sedative effects of desloratadine 5 mg with levocetirizine 5 mg in the treatment of chronic idiopathic urticaria.

Treatment with benfotiamine in patients with diabetic sensorimotor polyneuropathy: A double-blind, randomized, placebo-controlled, parallel group pilot study over 12 months